P14 MYELOID <i>TRIB1</i> PROMOTES EXPERIMENTAL ATHEROSCLEROSIS
Jessica Johnston(University of Sheffield), Endré Kiss-Toth(HUN-REN Szegedi Biológiai Kutatóközpont), Robert C. Bauer(Columbia University), Martin Turner(Babraham Institute), Stephen E. Hamby(University of Leicester), Daniel J. Rader(University of Pennsylvania), Adrienn Angyal(University of Sheffield), Alison H. Goodall(University of Leicester), Neil Dear(University of Leeds), Kajus Baidžajevas(University of Sheffield), Sheila Francis(Insigneo), S K Suvarna(University of Sheffield), Heather L. Wilson(University of Sheffield), Zoltán Hegedűs(HUN-REN Szegedi Biológiai Kutatóközpont), Carol C. Shoulders(Queen Mary University of London)
Cited by 1
Related Papers
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
|Nature Genetics|2006|2.3k
Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease
|New England Journal of Medicine|2016|1.5k
A variant in CDKAL1 influences insulin response and risk of type 2 diabetes
|Nature Genetics|2007|1.1k
Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ancestry meta-analysis
|Nature Genetics|2020|815
Association analyses based on false discovery rate implicate new loci for coronary artery disease
|Nature Genetics|2017|800